Nagano, Japan

Shigeru Yonekubo

This inventor holds 11 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 2008-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeru Yonekubo. Retrieved from https://idiyas.com/inventor/shigeru-yonekubo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 18.2


 

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 95(Granted Patents)


Location History:

  • Hotaka-machi, JP (2008 - 2009)
  • Azumino, JP (2008 - 2012)
  • Nagano, JP (2008 - 2012)

Company Filing History:


Years Active: 2008-2012

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Shigeru Yonekubo: Innovator in Medicinal Chemistry

Introduction

Shigeru Yonekubo is a prominent inventor based in Nagano, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrazole derivatives and nitrogenated fused ring derivatives. With a total of 11 patents to his name, Yonekubo's inventions are aimed at addressing critical health issues such as diabetes and hormone-dependent diseases.

Latest Patents

Yonekubo's latest patents include a range of medicinal compositions that exhibit excellent inhibitory activity in human SGLT1. These pyrazole derivatives are designed for the prevention or treatment of diseases associated with hyperglycemia, including diabetes and obesity. Another notable patent involves nitrogen-containing fused ring derivatives that possess GnRH antagonistic activity, which are useful for treating sex hormone-dependent diseases. These compounds are accompanied by pharmaceutical compositions and medicinal uses that highlight their potential in modern medicine.

Career Highlights

Throughout his career, Yonekubo has been associated with Kissei Pharmaceutical Co., Ltd., where he has played a vital role in advancing pharmaceutical research and development. His work has not only contributed to the scientific community but has also paved the way for new therapeutic options for patients suffering from various medical conditions.

Collaborations

Yonekubo has collaborated with notable colleagues such as Nobuhiko Fushimi and Hirotaka Teranishi. These partnerships have fostered a collaborative environment that enhances innovation and drives forward the development of new medicinal solutions.

Conclusion

Shigeru Yonekubo's contributions to medicinal chemistry through his patents and collaborations underscore his importance as an inventor in the pharmaceutical industry. His work continues to impact the field positively, offering hope for effective treatments for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…